Skip to main content
. Author manuscript; available in PMC: 2017 Mar 11.
Published in final edited form as: Neuroscience. 2016 Jan 11;317:121–129. doi: 10.1016/j.neuroscience.2016.01.005

Fig. 3. Effect of the mast cell degranulator, compound 48/80, on GTN-induced delayed onset hyperalgesia.

Fig. 3

Three daily injection of compound 48/80 (see Methods section for details) to deplete mast cells of their pronociceptive mediators markedly attenuated GTN-induced hyperalgesia (one-tailed Student’s t-test, P<0.0001).

HHS Vulnerability Disclosure